Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 4
2000 1
2001 1
2002 3
2004 6
2005 10
2006 6
2007 9
2008 3
2009 5
2010 2
2011 2
2012 1
2015 4
2016 2
2017 4
2018 6
2019 9
2020 7
2021 7
2022 12
2023 18
2024 9

Text availability

Article attribute

Article type

Publication date

Search Results

123 results

Results by year

Filters applied: . Clear all
Page 1
Calpain-mediated Mechanoptosis in Breast Adenocarcinoma.
Metaxas GI, Spyropoulou D, Mastronikoli S, Tsiambas E, Falidas E, Marinopoulos S, Manaios L, Davris D, Fotiades P, Peschos D, Dimitrakakis C. Metaxas GI, et al. Among authors: peschos d. Cancer Diagn Progn. 2023 May 3;3(3):297-301. doi: 10.21873/cdp.10215. eCollection 2023 May-Jun. Cancer Diagn Progn. 2023. PMID: 37168957 Free PMC article. Review.
Mutational Signatures in Salivary Gland Carcinomas.
Chrysovergis A, Papanikolaou V, Spyropoulou D, Roukas D, Asimakopoulos AD, Papanastasiou G, Mastronikoli S, Falidas E, Papouliakos S, Tsiambas E, Pantos P, Ragos V, Peschos D, Mastronikolis N, Kyrodimos E. Chrysovergis A, et al. Among authors: peschos d. Cancer Diagn Progn. 2023 Jul 3;3(4):411-415. doi: 10.21873/cdp.10233. eCollection 2023 Jul-Aug. Cancer Diagn Progn. 2023. PMID: 37405215 Free PMC article. Review.
Anti-EGFR/BRAF-Tyrosine Kinase Inhibitors in Thyroid Carcinoma.
Papanikolaou V, Kyrodimos E, Mastronikolis N, Asimakopoulos AD, Papanastasiou G, Tsiambas E, Spyropoulou D, Katsinis S, Manoli A, Papouliakos S, Pantos P, Ragos V, Peschos D, Chrysovergis A. Papanikolaou V, et al. Among authors: peschos d. Cancer Diagn Progn. 2023 Mar 3;3(2):151-156. doi: 10.21873/cdp.10194. eCollection 2023 Mar-Apr. Cancer Diagn Progn. 2023. PMID: 36875315 Free PMC article. Review.
c-Jun/c-Fos complex in laryngeal squamous cell carcinoma.
Tsiambas E, Mastronikolis N, P Fotiades P, Kyrodimos E, Chrysovergis A, Papanikolaou V, Mastronikolis S, Peschos D, Roukas D, Ragos V. Tsiambas E, et al. Among authors: peschos d. J BUON. 2020 Mar-Apr;25(2):618-620. J BUON. 2020. PMID: 32521843 Free article. Review.
Vasculogenic mimicry: lessons from melanocytic tumors.
Spiliopoulos K, Peschos D, Batistatou A, Ntountas I, Agnantis N, Kitsos G. Spiliopoulos K, et al. Among authors: peschos d. In Vivo. 2015 May-Jun;29(3):309-17. In Vivo. 2015. PMID: 25977376 Review.
Epigenetic Mechanisms in Breast Adenocarcinoma: Novel DNA Methylation Patterns.
Metaxas GI, Tsiambas E, Marinopoulos S, Spyropoulou D, Manaios L, Adamopoulou M, Falidas E, Peschos D, Kalkani H, Dimitrakakis C. Metaxas GI, et al. Among authors: peschos d. Cancer Diagn Progn. 2022 Nov 3;2(6):603-608. doi: 10.21873/cdp.10149. eCollection 2022 Nov-Dec. Cancer Diagn Progn. 2022. PMID: 36340455 Free PMC article. Review.
PTEN Deregulation Mechanisms in Salivary Gland Carcinomas.
Papanikolaou V, Chrysovergis A, Adamopoulou M, Spyropoulou D, Roukas D, Papanastasiou G, Mastronikoli S, Papouliakos S, Manaios L, Tsiambas E, Pantos P, Ragos V, Fotiades P, Peschos D, Mastronikolis N, Kyrodimos E. Papanikolaou V, et al. Among authors: peschos d. Cancer Diagn Progn. 2024 Jan 3;4(1):25-29. doi: 10.21873/cdp.10280. eCollection 2024 Jan-Feb. Cancer Diagn Progn. 2024. PMID: 38173659 Free PMC article. Review.
Impact of Ubiquitination Signaling Pathway Modifications on Oral Carcinoma.
Kyrodimos E, Chrysovergis A, Mastronikolis N, Tsiambas E, Manaios L, Roukas D, Pantos P, Ragos V, Peschos D, Papanikolaou V. Kyrodimos E, et al. Among authors: peschos d. Cancer Diagn Progn. 2022 Jan 3;2(1):1-6. doi: 10.21873/cdp.10069. eCollection 2022 Jan-Feb. Cancer Diagn Progn. 2022. PMID: 35399999 Free PMC article. Review.
Cell replacement therapy with stem cells in multiple sclerosis, a systematic review.
Christodoulou MV, Petkou E, Atzemoglou N, Gkorla E, Karamitrou A, Simos YV, Bellos S, Bekiari C, Kouklis P, Konitsiotis S, Vezyraki P, Peschos D, Tsamis KI. Christodoulou MV, et al. Among authors: peschos d. Hum Cell. 2024 Jan;37(1):9-53. doi: 10.1007/s13577-023-01006-1. Epub 2023 Nov 21. Hum Cell. 2024. PMID: 37985645 Free PMC article. Review.
DNA Mismatch Repair System Imbalances in Breast Adenocarcinoma.
Metaxas GI, Tsiambas E, Marinopoulos S, Adamopoulou M, Spyropoulou D, Falidas E, Davris D, Manaios L, Fotiades P, Mastronikoli S, Peschos D, Dimitrakakis C. Metaxas GI, et al. Among authors: peschos d. Cancer Diagn Progn. 2023 Mar 3;3(2):169-174. doi: 10.21873/cdp.10197. eCollection 2023 Mar-Apr. Cancer Diagn Progn. 2023. PMID: 36875308 Free PMC article. Review.
123 results